ClinicalTrials.gg
Drug

Rocuronium clinical trials

Also written Esmeron, Zemuron and ORG 9426.

studies test it
125
open now
13
in phase 3
11
first study started
2003

How each study uses Rocuronium is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Rocuronium studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Mar 1994 · ZEMURON · NDA 020214 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rocuronium
78
Rocuronium Bromide
12
Rocuronium 0.6 mg/kg
5
Bridion
2
Neuromuscular blocker
2

Brand

Esmeron
26
Zemuron
12

Development codes

ORG 9426
3
SCH 900085
1

In one entry with another drug

Given together, or one or the other

Rocuronium + sugammadex
3
Rocuronium and Sugammadex
2

Studies by the year they started

124 studies that test it; most in 2015 (16); 1 more planned to start later

Studies that test Rocuronium, by start year
YearStudies
20031
20042
20052
20062
20072
20081
20096
20101
20115
201210
20136
201412
201516
201610
201710
20184
20196
20203
20213
20225
20234
20245
20252
20266

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
1
Phase 2
10
Phase 3
11
Phase 4
53
No phase
47

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 114

Merck Sharp & Dohme LLC (8) · Seoul National University Bundang Hospital (6) · Herlev Hospital (5) · Seoul National University Hospital (5) · Rigshospitalet, Denmark (4) · Beth Israel Deaconess Medical Center (3) · Assiut University (3) · University of Texas Southwestern Medical Center (2)

Often tested with

Tested in the same studies.

Sugammadex (23) · Propofol (11) · Succinylcholine (7) · Sevoflurane (6) · Vecuronium (6) · Remifentanil (5) · Cisatracurium (5) · Ropivacaine (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Rocuronium is the comparator. A study of two new drugs counts under both.

  • 1HRS-9190 · Jiangsu HengRui Medicine Co., Ltd. · next primary completion Dec 2026
Reaching primary completion within a year · 4

Studies that test Rocuronium.

Studies

Open first, then newest update. How each study uses Rocuronium is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 125

See all 125 studies that test Rocuronium →

Given beside what is tested · 59 — Rocuronium is usual care or a partner of the new treatment

Showing 20 of 59.

As the comparator · 13 — what is tested is compared with Rocuronium

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call Rocuronium · ClinicalTrials.gg INT006646

  • MeSH (NLM) D000077123RocuroniumConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) WRE554RFEZROCURONIUMConfirmed FDA, NLM, Wikidata
  • RxNorm 68139Confirmed FDA, Wikidata
  • Wikidata Q185331rocuroniumConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C80999RocuroniumOne source FDA
  • DrugBank DB00728One source Wikidata

Also registered as rocuronium bromide (UNII I65MW4OFHZ · RxNorm 32521).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.